Semler Scientific (NASDAQ:SMLR) Experiences Unusually High Trading Volume - Is It Time to Buy?

Semsler Scientific, Inc. (NASDAQ:SMLR) experienced a notable increase in trading activity recently. On Friday, 149,046 shares were exchanged during midday trading, which marked a 42% decrease compared to the prior session's volume of 257,789 shares. The stock was last quoted at $62.10, having previously closed at $61.05.

Semler Scientific Stock Overview

The company's 50-day simple moving average stands at $35.16, while the 200-day moving average is at $31.74. Semler's market capitalization is approximately $487.87 million, with a price-to-earnings ratio of 29.78 and a beta value of 0.92.

Recent Earnings Highlights

On November 4th, Semler Scientific released its quarterly earnings report. The company announced earnings per share (EPS) of $0.72, which exceeded analysts' predictions of $0.37 by $0.35. Semler reported a net margin of 27.00% and a return on equity of 20.31%, alongside a quarterly revenue of $13.51 million.

Institutional Investor Activities

In recent months, several large institutional investors have adjusted their holdings in Semler Scientific. Cerity Partners LLC increased its stake by 91.5% during the third quarter, now owning 1,345,586 shares worth approximately $31.69 million after acquiring an additional 642,982 shares. Shariaportfolio Inc. also bought a new position valued at approximately $3.62 million during the same period. AQR Capital Management LLC increased its stake by 150.1% in the second quarter, owning 140,498 shares worth about $4.83 million after purchasing an additional 84,314 shares. Additionally, Geode Capital Management LLC and Dimensional Fund Advisors LP have also raised their stakes in Semler Scientific. Notably, institutional investors and hedge funds control about 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc. offers innovative technology solutions aimed at improving the clinical effectiveness and efficiency of healthcare providers across the United States. Their flagship product, QuantaFlo, is a quick, four-minute in-office blood flow test that allows healthcare providers to incorporate blood flow measurements into their evaluations of a patient’s vascular health.

Conclusion

With the stock trading activity gaining momentum and positive earnings in hand, some investors might wonder whether it is an opportune time to consider adding Semler Scientific to their portfolios. However, while the company holds a "Strong Buy" rating from analysts, there may be other stocks that are more favorable at this moment.

Semler, Stocks, Trading